Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
13 mars 2025 18h07 HE
|
Cellectis Inc.
○ UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD...
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
13 mars 2025 16h01 HE
|
aTyr Pharma, Inc.
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
12 mars 2025 08h30 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through...
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
12 mars 2025 08h00 HE
|
CG Oncology Inc.
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
12 mars 2025 02h00 HE
|
Zealand Pharma
Company announcement – No. 4 / 2025 Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with...
Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem
11 mars 2025 21h32 HE
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and WASHINGTON, March 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Matteo Paz,18, of Pasadena, CA,...
Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results
11 mars 2025 08h00 HE
|
Ovid Therapeutics Inc.
Stelios Papadopolous, Ph.D., a pioneering leader in biotech, appointed to Board of Directors; two industry veterans joined management team as Ovid prepares to take OV329 into patient trials and move...
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
11 mars 2025 08h00 HE
|
Madrigal Pharmaceuticals, Inc.
Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a...
Alumis to Present at Leerink's 2025 Global Healthcare Conference
10 mars 2025 08h00 HE
|
Alumis Inc.
Alumis to Present at Leerink's 2025 Global Healthcare Conference
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
10 mars 2025 07h30 HE
|
Plus Therapeutics Inc.
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement